Font Size: a A A
Keyword [End-stage Liver Disease]
Result: 21 - 40 | Page: 2 of 5
21. Contrast Of Hbv Recurrence On Patients With Hbv-related End-stage Liver Disease After Orthotopic Liver Transplantation With Different Therapeutics(80 Cases Reported)
22. Evaluation Of Indocyanine Green Clearance Test(ICGR15) And Model For End-stage Liver Disease(MELD) For Estimation Of Short-term Prognosis In Patients With Liver Failure
23. Variation Tendency Of The Level Of Fasting Plasma Glucose In Patients With Decompensated Liver Cirrhosis
24. Application Of The Model For End-stage Liver Disease And Child-Turcotte-Pugh System To Evaluate The Surgical Prognosis Of Patients With Hepatic Alveolar Echinococcosis
25. The Research Of Anti-endotoxemia Therapy In Treating Chronic Severe Hepatitis B
26. Clinical Study Of Liver Function And Hemodynamics Pre-and Post- Devascularization In Portal Hypertension
27. The Value Of MELD Score And Serum Total Cholesterol In Predicting The Prognsis Of Patients With Decompensated Liver Cirrhosis Caused By Hepatitis B Virus
28. Stude Of The Effect Of Allogeneic Mesenchymal Stem Cells(MSCs) In The Treatment Of The End Stage Liver Disease
29. The Application Of Indocyanine Green Clearance Test In The Assessment Of End-stage Liver Disease
30. Value Of MELD To Assess The Short-term Prognosis Of Severe Hepatitis By Artificial Liver Treatment
31. A Clinical Report Of7Cases Of Combined Liver-kidney Transplantation
32. The Correlation Study On Expression Change Of Plasma SRB1、CD36Scavenger Receptor Before And After Liver Transplantation With Atherosclerosis
33. Analysis Of Post Liver Transplantation Complications And Risk Factors For Death And Clinical Research Of Predict Survival Rate By MELD Score And CTP Classification System
34. The Study Of The Association On Gene Polymorph-Isms Of Plasma SR-B1with Atherosclerosis For The Patients With Liver Transplantation
35. Study Of Clinical Characteristics Of Non-biliary Complications And Prediction Of Prognosis After Liver Transplantation
36. The Prognostic Assessment Of Model For End-stage Liver Disease (MELD) And Alpha Fetal Protein In Patients With Liver Failure
37. Evaluation Of Clinical Efficacy Of Artificial Liver Technology Used Plasma Exchange And MARS And Construction Of Nursing Countermeasures
38. The Relevant Mechanism Of Atherosclerosis After Liver Transplantation
39. Analysis Of Post Liver Transplantation Risk Factors For Infection By MELD Score And Predicte Short-term Survival Rate For End-stage Liver Disease Post Liver Transplantation
40. The Role Of Serum Procalcitonin Assay For Diagnosis Of Bacterial Peritonitis In End-stage Liver Disease
  <<First  <Prev  Next>  Last>>  Jump to